217 related articles for article (PubMed ID: 31335362)
1. Combined Hepatocellular Cholangiocarcinoma: A Population-Based Retrospective Study.
Ramai D; Ofosu A; Lai JK; Reddy M; Adler DG
Am J Gastroenterol; 2019 Sep; 114(9):1496-1501. PubMed ID: 31335362
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Clinical Features and Outcomes Between Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in the United States.
Lee YT; Wang JJ; Luu M; Noureddin M; Nissen NN; Patel TC; Roberts LR; Singal AG; Gores GJ; Yang JD
Hepatology; 2021 Nov; 74(5):2622-2632. PubMed ID: 34114675
[TBL] [Abstract][Full Text] [Related]
3. Combined hepatocellular-cholangiocarcinoma: a population level analysis of incidence and mortality trends.
Wang J; Li E; Yang H; Wu J; Lu HC; Yi C; Lei J; Liao W; Wu L
World J Surg Oncol; 2019 Feb; 17(1):43. PubMed ID: 30813932
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic Characteristics of Hepatocellular Carcinoma With Reactive Ductule-like Components, a Subset of Liver Cancer Currently Classified as Combined Hepatocellular-Cholangiocarcinoma With Stem-Cell Features, Typical Subtype.
Shibahara J; Hayashi A; Misumi K; Sakamoto Y; Arita J; Hasegawa K; Kokudo N; Fukayama M
Am J Surg Pathol; 2016 May; 40(5):608-16. PubMed ID: 26735856
[TBL] [Abstract][Full Text] [Related]
5. Combined hepatocellular-cholangiocarcinoma: a population-level analysis of an uncommon primary liver tumor.
Garancini M; Goffredo P; Pagni F; Romano F; Roman S; Sosa JA; Giardini V
Liver Transpl; 2014 Aug; 20(8):952-9. PubMed ID: 24777610
[TBL] [Abstract][Full Text] [Related]
6. Survival outcomes of combined hepatocellular-cholangiocarcinoma compared with intrahepatic cholangiocarcinoma: A SEER population-based cohort study.
Yang Z; Shi G
Cancer Med; 2022 Feb; 11(3):692-704. PubMed ID: 34862762
[TBL] [Abstract][Full Text] [Related]
7. Combined hepatocellular-cholangiocarcinoma: An update on epidemiology, classification, diagnosis and management.
Schizas D; Mastoraki A; Routsi E; Papapanou M; Tsapralis D; Vassiliu P; Toutouzas K; Felekouras E
Hepatobiliary Pancreat Dis Int; 2020 Dec; 19(6):515-523. PubMed ID: 32753331
[TBL] [Abstract][Full Text] [Related]
8. Clinical and pathological features of combined hepatocellular-cholangiocarcinoma compared with other liver cancers.
Wakizaka K; Yokoo H; Kamiyama T; Ohira M; Kato K; Fujii Y; Sugiyama K; Okada N; Ohata T; Nagatsu A; Shimada S; Orimo T; Kamachi H; Taketomi A
J Gastroenterol Hepatol; 2019 Jun; 34(6):1074-1080. PubMed ID: 30462849
[TBL] [Abstract][Full Text] [Related]
9. Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors.
Jarnagin WR; Weber S; Tickoo SK; Koea JB; Obiekwe S; Fong Y; DeMatteo RP; Blumgart LH; Klimstra D
Cancer; 2002 Apr; 94(7):2040-6. PubMed ID: 11932907
[TBL] [Abstract][Full Text] [Related]
10. Comparison of clinical characteristics of combined hepatocellular-cholangiocarcinoma and other primary liver cancers.
Lee CH; Hsieh SY; Chang CJ; Lin YJ
J Gastroenterol Hepatol; 2013 Jan; 28(1):122-7. PubMed ID: 23034166
[TBL] [Abstract][Full Text] [Related]
11. Trends in Incidence and Prognostic Factors of Two Subtypes of Primary Liver Cancers: A Surveillance, Epidemiology, and End Results-Based Population Study.
Yao J; Liang X; Liu Y; Li S; Zheng M
Cancer Control; 2022; 29():10732748211051548. PubMed ID: 35147456
[TBL] [Abstract][Full Text] [Related]
12. Combined hepatocellular and cholangiocarcinoma originating from the same clone: a pathomolecular evidence-based study.
Zhao Q; Yu WL; Lu XY; Dong H; Gu YJ; Sheng X; Cong WM; Wu MC
Chin J Cancer; 2016 Aug; 35(1):82. PubMed ID: 27552844
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma in a low-endemic area: rising incidence and improved survival.
Witjes CD; Karim-Kos HE; Visser O; van den Akker SA; de Vries E; Ijzermans JN; de Man RA; Coebergh JW; Verhoef C
Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):450-7. PubMed ID: 22273986
[TBL] [Abstract][Full Text] [Related]
14. Intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma in patients undergoing liver transplantation: a Spanish matched cohort multicenter study.
Sapisochin G; de Lope CR; Gastaca M; de Urbina JO; López-Andujar R; Palacios F; Ramos E; Fabregat J; Castroagudín JF; Varo E; Pons JA; Parrilla P; González-Diéguez ML; Rodriguez M; Otero A; Vazquez MA; Zozaya G; Herrero JI; Antolin GS; Perez B; Ciria R; Rufian S; Fundora Y; Ferron JA; Guiberteau A; Blanco G; Varona MA; Barrera MA; Suarez MA; Santoyo J; Bruix J; Charco R
Ann Surg; 2014 May; 259(5):944-52. PubMed ID: 24441817
[TBL] [Abstract][Full Text] [Related]
15. Trends in Incidence and Factors Affecting Survival of Patients With Cholangiocarcinoma in the United States.
Mukkamalla SKR; Naseri HM; Kim BM; Katz SC; Armenio VA
J Natl Compr Canc Netw; 2018 Apr; 16(4):370-376. PubMed ID: 29632056
[No Abstract] [Full Text] [Related]
16. Coffee Consumption and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma by Sex: The Liver Cancer Pooling Project.
Petrick JL; Freedman ND; Graubard BI; Sahasrabuddhe VV; Lai GY; Alavanja MC; Beane-Freeman LE; Boggs DA; Buring JE; Chan AT; Chong DQ; Fuchs CS; Gapstur SM; Gaziano JM; Giovannucci EL; Hollenbeck AR; King LY; Koshiol J; Lee IM; Linet MS; Palmer JR; Poynter JN; Purdue MP; Robien K; Schairer C; Sesso HD; Sigurdson AJ; Zeleniuch-Jacquotte A; Wactawski-Wende J; Campbell PT; McGlynn KA
Cancer Epidemiol Biomarkers Prev; 2015 Sep; 24(9):1398-406. PubMed ID: 26126626
[TBL] [Abstract][Full Text] [Related]
17. Treatment and survival of resected and unresected distal cholangiocarcinoma: a nationwide study.
Strijker M; Belkouz A; van der Geest LG; van Gulik TM; van Hooft JE; de Meijer VE; Haj Mohammad N; de Reuver PR; Verheij J; de Vos-Geelen J; Wilmink JW; Groot Koerkamp B; Klümpen HJ; Besselink MG;
Acta Oncol; 2019 Jul; 58(7):1048-1055. PubMed ID: 30907207
[No Abstract] [Full Text] [Related]
18. Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The Liver Cancer Pooling Project.
Petrick JL; Campbell PT; Koshiol J; Thistle JE; Andreotti G; Beane-Freeman LE; Buring JE; Chan AT; Chong DQ; Doody MM; Gapstur SM; Gaziano JM; Giovannucci E; Graubard BI; Lee IM; Liao LM; Linet MS; Palmer JR; Poynter JN; Purdue MP; Robien K; Rosenberg L; Schairer C; Sesso HD; Sinha R; Stampfer MJ; Stefanick M; Wactawski-Wende J; Zhang X; Zeleniuch-Jacquotte A; Freedman ND; McGlynn KA
Br J Cancer; 2018 Apr; 118(7):1005-1012. PubMed ID: 29520041
[TBL] [Abstract][Full Text] [Related]
19. Rising incidence of primary liver cancer in Brunei Darussalam.
Chong RJ; Abdullah MS; Hossain MM; Telisinghe PU; Chong VH
Asian Pac J Cancer Prev; 2013; 14(6):3473-7. PubMed ID: 23886131
[TBL] [Abstract][Full Text] [Related]
20. Post-resection Prognosis of Combined Hepatocellular Carcinoma-Cholangiocarcinoma According to the 2010 WHO Classification.
Jung DH; Hwang S; Hong SM; Chung YK; Song GW; Lee YJ; Kim KH; Ahn CS; Moon DB; Ha TY; Park GC; Lee HC; Lim YS; Yu ES; Lee SG
World J Surg; 2017 May; 41(5):1347-1357. PubMed ID: 27896409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
